{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:10:53Z","timestamp":1789175453238,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T00:00:00Z","timestamp":1279670400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The anti-epileptic drug valproic acid (VPA) has attracted attention as an anti-cancer agent.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present study investigated effects of VPA exposure on histone deacetylase (HDAC) inhibition, cell growth, cell speed, and the degree of Erk1\/2 phosphorylation in 10 cell lines (BT4C, BT4Cn, U87MG, N2a, PC12-E2, CSML0, CSML100, HeLa, L929, Swiss 3T3).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>VPA induced significant histone deacetylase (HDAC) inhibition in most of the cell lines, but the degree of inhibition was highly cell type-specific. Moreover, cell growth, motility and the degree of Erk1\/2 phosphorylation were inhibited, activated, or unaffected by VPA in a cell type-specific manner. Importantly, no relationship was found between the effects of VPA on HDAC inhibition and changes in the degree of Erk1\/2 phosphorylation, cell growth, or motility. In contrast, VPA-induced modulation of the MAPK pathway downstream of Ras but upstream of MEK (i.e., at the level of Raf) was important for changes in cell speed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results suggest that VPA can modulate the degree of Erk1\/2 phosphorylation in a manner unrelated to HDAC inhibition and emphasize that changes in the degree of Erk1\/2 phosphorylation are also important for the anti-cancer properties of VPA.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2407-10-383","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T18:13:57Z","timestamp":1279736037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1\/2 phosphorylation"],"prefix":"10.1186","volume":"10","author":[{"given":"Kamil","family":"Gotfryd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Skladchikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene A","family":"Lepekhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Berezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S","family":"Walmod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,21]]},"reference":[{"key":"2182_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","volume":"9","author":"CU Johannessen","year":"2003","unstructured":"Johannessen CU, Johannessen SI: Valproate: past, present, and future. CNS Drug Rev. 2003, 9: 199-216. 10.1111\/j.1527-3458.2003.tb00249.x.","journal-title":"CNS Drug Rev"},{"key":"2182_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14712\/fb2007053020037","volume":"53","author":"M Kostrouchova","year":"2007","unstructured":"Kostrouchova M, Kostrouch Z, Kostrouchova M: Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biologica (Praha). 2007, 53: 37-49.","journal-title":"Folia Biologica (Praha)"},{"key":"2182_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/cncr.22891","volume":"110","author":"A Kuendgen","year":"2007","unstructured":"Kuendgen A, Gattermann N: Valproic acid for the treatment of myeloid malignancies. Cancer. 2007, 110: 943-954. 10.1002\/cncr.22891.","journal-title":"Cancer"},{"key":"2182_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","volume":"34","author":"A Duenas-Gonzalez","year":"2008","unstructured":"Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C, Perez-Cardenas E, de la Cruz-Hernandez E, Herrera LA: Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treatment Reviews. 2008, 34: 206-222. 10.1016\/j.ctrv.2007.11.003.","journal-title":"Cancer Treatment Reviews"},{"key":"2182_CR5","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.2174\/138161207782360528","volume":"13","author":"M Michaelis","year":"2007","unstructured":"Michaelis M, Doerr HW, Cinatl J: Valproic acid as anti-cancer drug. Current Pharmaceutical Design. 2007, 13: 3378-3393. 10.2174\/138161207782360519.","journal-title":"Current Pharmaceutical Design"},{"key":"2182_CR6","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS: Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biological Chemistry. 2001, 276: 36734-36741. 10.1074\/jbc.M101287200.","journal-title":"Journal of Biological Chemistry"},{"key":"2182_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/med.10017","volume":"22","author":"RA Blaheta","year":"2002","unstructured":"Blaheta RA, Cinatl J: Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev. 2002, 22: 492-511. 10.1002\/med.10017.","journal-title":"Med Res Rev"},{"key":"2182_CR8","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1242\/jcs.01481","volume":"117","author":"C Huang","year":"2004","unstructured":"Huang C, Jacobson K, Schaller MD: MAP kinases and cell migration. Journal of Cell Science. 2004, 117: 4619-4628. 10.1242\/jcs.01481.","journal-title":"Journal of Cell Science"},{"key":"2182_CR9","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","volume":"26","author":"S Meloche","year":"2007","unstructured":"Meloche S, Pouyssegur J: The ERK1\/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007, 26: 3227-3239. 10.1038\/sj.onc.1210414.","journal-title":"Oncogene"},{"key":"2182_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02699050500284218","volume":"24","author":"S Yoon","year":"2006","unstructured":"Yoon S, Seger R: The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 2006, 24: 21-44. 10.1080\/02699050500284218.","journal-title":"Growth Factors"},{"key":"2182_CR11","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","volume":"26","author":"MM McKay","year":"2007","unstructured":"McKay MM, Morrison DK: Integrating signals from RTKs to ERK\/MAPK. Oncogene. 2007, 26: 3113-3121. 10.1038\/sj.onc.1210394.","journal-title":"Oncogene"},{"key":"2182_CR12","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/sj.onc.1202251","volume":"17","author":"N Dhanasekaran","year":"1998","unstructured":"Dhanasekaran N, Premkumar Reddy E: Signaling by dual specificity kinases. Oncogene. 1998, 17: 1447-1455. 10.1038\/sj.onc.1202251.","journal-title":"Oncogene"},{"key":"2182_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/excr.1999.4689","volume":"253","author":"C Hagemann","year":"1999","unstructured":"Hagemann C, Rapp UR: Isotype-specific functions of Raf kinases. Experimental Cell Research. 1999, 253: 34-46. 10.1006\/excr.1999.4689.","journal-title":"Experimental Cell Research"},{"key":"2182_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jcp.21246","volume":"213","author":"E Rozengurt","year":"2007","unstructured":"Rozengurt E: Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol. 2007, 213: 589-602. 10.1002\/jcp.21246.","journal-title":"J Cell Physiol"},{"key":"2182_CR15","first-page":"347","volume":"21","author":"MM Knupfer","year":"2001","unstructured":"Knupfer MM, Pulzer F, Schindler I, Hernaiz Driever P, Knupfer H, Keller E: Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro. Anticancer Res. 2001, 21: 347-351.","journal-title":"Anticancer Res"},{"key":"2182_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ajh.10161","volume":"71","author":"O Witt","year":"2002","unstructured":"Witt O, Monkemeyer S, Kanbach K, Pekrun A: Induction of fetal hemoglobin synthesis by valproate: modulation of MAP kinase pathways. American Journal of Hematology. 2002, 71: 45-46. 10.1002\/ajh.10161.","journal-title":"American Journal of Hematology"},{"key":"2182_CR17","doi-asserted-by":"publisher","first-page":"31674","DOI":"10.1074\/jbc.M104309200","volume":"276","author":"PX Yuan","year":"2001","unstructured":"Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G: The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry. 2001, 276: 31674-31683. 10.1074\/jbc.M104309200.","journal-title":"Journal of Biological Chemistry"},{"key":"2182_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.neuropharm.2006.09.017","volume":"52","author":"K Gotfryd","year":"2007","unstructured":"Gotfryd K, Owczarek S, Hoffmann K, Klementiev B, Nau H, Berezin V, Bock E, Walmod PS: Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement. Neuropharmacology. 2007, 52: 764-778. 10.1016\/j.neuropharm.2006.09.017.","journal-title":"Neuropharmacology"},{"key":"2182_CR19","first-page":"59","volume":"161","author":"PS Walmod","year":"2001","unstructured":"Walmod PS, Hartmann-Petersen R, Berezin A, Prag S, Kiselyov VV, Berezin V, Bock E: Evaluation of individual-cell motility. Methods in Molecular Biology. 2001, 161: 59-83.","journal-title":"Methods in Molecular Biology"},{"key":"2182_CR20","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.cellsig.2007.04.012","volume":"19","author":"AK Pullikuth","year":"2007","unstructured":"Pullikuth AK, Catling AD: Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell Signal. 2007, 19: 1621-1632. 10.1016\/j.cellsig.2007.04.012.","journal-title":"Cell Signal"},{"key":"2182_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/(SICI)1097-0169(1998)40:3<220::AID-CM2>3.0.CO;2-H","volume":"40","author":"PS Walmod","year":"1998","unstructured":"Walmod PS, Foley A, Berezin A, Ellerbeck U, Nau H, Bock E, Berezin V: Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues. Cell Motilility and the Cytoskeleton. 1998, 40: 220-237. 10.1002\/(SICI)1097-0169(1998)40:3<220::AID-CM2>3.0.CO;2-H.","journal-title":"Cell Motilility and the Cytoskeleton"},{"key":"2182_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/oxfordjournals.jbchem.a022519","volume":"126","author":"T Yamamoto","year":"1999","unstructured":"Yamamoto T, Taya S, Kaibuchi K: Ras-Induced Transformation and Signaling Pathway. J Biochem. 1999, 126: 799-803.","journal-title":"J Biochem"},{"key":"2182_CR23","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, Heinzel T: Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO Journal. 2001, 20: 6969-6978. 10.1093\/emboj\/20.24.6969.","journal-title":"EMBO Journal"},{"key":"2182_CR24","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2174\/0929867023369763","volume":"9","author":"RA Blaheta","year":"2002","unstructured":"Blaheta RA, Nau H, Michaelis M, Cinatl J: Valproate and valproate-analogues: potent tools to fight against cancer. Curr Med Chem. 2002, 9: 1417-1433.","journal-title":"Curr Med Chem"},{"key":"2182_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ijc.20774","volume":"114","author":"K Camphausen","year":"2005","unstructured":"Camphausen K, Cerna D, Scott T, Sproull M, Burgan WE, Cerra MA, Fine H, Tofilon PJ: Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int J Cancer. 2005, 114: 380-386. 10.1002\/ijc.20774.","journal-title":"Int J Cancer"},{"key":"2182_CR26","doi-asserted-by":"publisher","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","volume":"66","author":"Q Xia","year":"2006","unstructured":"Xia Q, Sung J, Chowdhury W, Chen CL, Hoti N, Shabbeer S, Carducci M, Rodriguez R: Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo. Cancer Res. 2006, 66: 7237-7244. 10.1158\/0008-5472.CAN-05-0487.","journal-title":"Cancer Res"},{"key":"2182_CR27","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1523\/JNEUROSCI.5747-03.2004","volume":"24","author":"Y Hao","year":"2004","unstructured":"Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G: Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci. 2004, 24: 6590-6599. 10.1523\/JNEUROSCI.5747-03.2004.","journal-title":"J Neurosci"},{"key":"2182_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1399-5618.2004.00164.x","volume":"7","author":"E Di Daniel","year":"2005","unstructured":"Di Daniel E, Mudge AW, Maycox PR: Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. 2005, 7: 33-41. 10.1111\/j.1399-5618.2004.00164.x.","journal-title":"Bipolar Disord"},{"key":"2182_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.cdd.4401759","volume":"13","author":"M Michaelis","year":"2006","unstructured":"Michaelis M, Suhan T, Michaelis UR, Beek K, Rothweiler F, Tausch L, Werz O, Eikel D, Zornig M, Nau H, Fleming I, Doerr HW, Cinatl J: Valproic acid induces extracellular signal-regulated kinase 1\/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ. 2006, 13: 446-453. 10.1038\/sj.cdd.4401759.","journal-title":"Cell Death Differ"},{"key":"2182_CR30","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.yexcr.2006.01.017","volume":"312","author":"F Vulcano","year":"2006","unstructured":"Vulcano F, Ciccarelli C, Mattia G, Marampon F, Giampiero M, Milazzo L, Pascuccio M, Zani BM, Giampaolo A, Hassan HJ: HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. Experimental Cell Research. 2006, 312: 1590-1597. 10.1016\/j.yexcr.2006.01.017.","journal-title":"Experimental Cell Research"},{"key":"2182_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2004.11.029","volume":"225","author":"JW Jung","year":"2005","unstructured":"Jung JW, Cho SD, Ahn NS, Yang SR, Park JS, Jo EH, Hwang JW, Jung JY, Kim SH, Kang KS, Lee YS: Ras\/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate. Cancer Lett. 2005, 225: 199-206. 10.1016\/j.canlet.2004.11.029.","journal-title":"Cancer Lett"},{"key":"2182_CR32","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4161\/cbt.2.5.454","volume":"2","author":"C Yu","year":"2003","unstructured":"Yu C, Subler M, Rahmani M, Reese E, Krystal G, Conrad D, Dent P, Grant S: Induction of apoptosis in BCR\/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF\/MEK\/ERK and JNK pathways. Cancer Biol Ther. 2003, 2: 544-551.","journal-title":"Cancer Biol Ther"},{"key":"2182_CR33","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1167\/iovs.05-0369","volume":"46","author":"M Michaelis","year":"2005","unstructured":"Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gumbel H, Doerr HW, Nau H, Cinatl J: Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Invest Ophthalmol Vis Sci. 2005, 46: 3451-3457. 10.1167\/iovs.05-0369.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2182_CR34","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1677\/ERC-07-0096","volume":"14","author":"MG Catalano","year":"2007","unstructured":"Catalano MG, Poli R, Pugliese M, Fortunati N, Boccuzzi G: Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Endocr Relat Cancer. 2007, 14: 839-845. 10.1677\/ERC-07-0096.","journal-title":"Endocr Relat Cancer"},{"key":"2182_CR35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","volume":"64","author":"N Gurvich","year":"2004","unstructured":"Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS: Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 2004, 64: 1079-1086. 10.1158\/0008-5472.CAN-03-0799.","journal-title":"Cancer Res"},{"key":"2182_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","volume":"27","author":"X Zhang","year":"2007","unstructured":"Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N, Parsons JT, Yang XJ, Dent SR, Yao TP, Lane WS, Seto E: HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell. 2007, 27: 197-213. 10.1016\/j.molcel.2007.05.033.","journal-title":"Mol Cell"},{"key":"2182_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1124\/pr.107.00106","volume":"60","author":"T Boutros","year":"2008","unstructured":"Boutros T, Chevet E, Metrakos P: Mitogen-activated protein (MAP) kinase\/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev. 2008, 60: 261-310. 10.1124\/pr.107.00106.","journal-title":"Pharmacol Rev"},{"key":"2182_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0890-6238(02)00059-X","volume":"16","author":"LC Fuller","year":"2002","unstructured":"Fuller LC, Cornelius SK, Murphy CW, Wiens DJ: Neural crest cell motility in valproic acid. Reproductive Toxicology. 2002, 16: 825-839. 10.1016\/S0890-6238(02)00059-X.","journal-title":"Reproductive Toxicology"},{"key":"2182_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/jpet.106.106658","volume":"319","author":"CL Chen","year":"2006","unstructured":"Chen CL, Sung J, Cohen M, Chowdhury WH, Sachs MD, Li Y, Lakshmanan Y, Yung BY, Lupold SE, Rodriguez R: Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells. J Pharmacol Exp Ther. 2006, 319: 533-542. 10.1124\/jpet.106.106658.","journal-title":"J Pharmacol Exp Ther"},{"key":"2182_CR40","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/jnr.20765","volume":"83","author":"LA De Girolamo","year":"2006","unstructured":"De Girolamo LA, Billett EE: Role of extracellular-regulated kinase and c-Jun NH2-terminal kinase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurofilament phosphorylation. J Neurosci Res. 2006, 83: 680-693. 10.1002\/jnr.20765.","journal-title":"J Neurosci Res"},{"key":"2182_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bjc.6601488","volume":"90","author":"E O'Neill","year":"2004","unstructured":"O'Neill E, Kolch W: Conferring specificity on the ubiquitous Raf\/MEK signalling pathway. Br J Cancer. 2004, 90: 283-288. 10.1038\/sj.bjc.6601488.","journal-title":"Br J Cancer"},{"key":"2182_CR42","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1200\/JCO.2005.08.036","volume":"23","author":"M Beeram","year":"2005","unstructured":"Beeram M, Patnaik A, Rowinsky EK: Raf: a strategic target for therapeutic development against cancer. J Clin Oncol. 2005, 23: 6771-6790. 10.1200\/JCO.2005.08.036.","journal-title":"J Clin Oncol"},{"key":"2182_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","volume":"85","author":"CM Das","year":"2007","unstructured":"Das CM, Aguilera D, Vasquez H, Prasad P, Zhang M, Wolff JE, Gopalakrishnan V: Valproic acid induces p21 and topoisomerase-II (alpha\/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. J Neurooncol. 2007, 85: 159-170. 10.1007\/s11060-007-9402-7.","journal-title":"J Neurooncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-383.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-383\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-383.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T06:03:56Z","timestamp":1740290636000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2182"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-383","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,21]]},"assertion":[{"value":"14 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"383"}}